Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Chronic-Dose Safety and Efficacy Study of an Albuterol Metered Dose Inhaler (MDI) Inhaler Using a Hydrofluoroalkane (HFA) Propellant In Pediatric Asthmatics
This study has been completed.
Study NCT00577655 Information provided by Teva Branded Pharmaceutical Products, R&D Inc.
First Received on December 18, 2007. Last Updated on April 11, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Immune System Diseases
Lung Diseases, Obstructive
Respiratory Tract Diseases
Interventions listed in this trial
More general drug interventions related to this trial
Adrenergic beta-2 Receptor Agonists
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Physiological Effects of Drugs
Reproductive Control Agents
Respiratory System Agents
Sponsors listed in this trial
Teva Branded Pharmaceutical Products, R&D Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers